BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ju Hyun Shim, Joong-Won Park, Ji Hoon Kim, Min An, Sun-Young Kong, Byung-Ho Nam, Joon-Il Choi, Hyun Beom Kim, Woo Jin Lee, Chang-Min Kim. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patientsCancer Science 2008;  doi: 10.1111/j.1349-7006.2008.00909.x
2
Daisaku Yamada, Shogo Kobayashi, Hirofumi Yamamoto, Yoshito Tomimaru, Takehiro Noda, Mamoru Uemura, Hiroshi Wada, Shigeru Marubashi, Hidetoshi Eguchi, Masahiro Tanemura, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. Role of the Hypoxia-Related Gene, JMJD1A, in Hepatocellular Carcinoma: Clinical Impact on Recurrence after Hepatic ResectionAnnals of Surgical Oncology 2012; 19(S3): 355 doi: 10.1245/s10434-011-1797-x
3
Hai-Lin Li, Wen-Bin Ji, Rui Zhao, Wei-Dong Duan, Yong-Wei Chen, Xian-Qiang Wang, Qiang Yu, Ying Luo, Jia-Hong Dong. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: Retrospective analysisWorld Journal of Gastroenterology 2015; 21(12): 3599-3606 doi: 10.3748/wjg.v21.i12.3599
4
Katerina Malagari, Mary Pomoni, Alexis Kelekis, Anastasia Pomoni, Spyros Dourakis, Themis Spyridopoulos, Hippokratis Moschouris, Emmanouil Emmanouil, Spyros Rizos, Dimitrios Kelekis. Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular CarcinomaCardioVascular and Interventional Radiology 2010; 33(3): 541 doi: 10.1007/s00270-009-9750-0
5
Bingru Xie, David H. Wang, Stuart Jon Spechler. Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic ReviewDigestive Diseases and Sciences 2012; 57(5): 1122 doi: 10.1007/s10620-012-2136-1
6
Paolo Giunchedi, Marcello Maestri, Elisabetta Gavini, Paolo Dionigi, Giovanna Rassu. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1Expert Opinion on Drug Delivery 2013; 10(5): 679 doi: 10.1517/17425247.2013.770733
7
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsCritical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005
8
Mona El-Azab, Hailemichael Hishe, Yasser Moustafa, El-Sayed El-Awady. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing miceEuropean Journal of Pharmacology 2011; 652(1-3): 7 doi: 10.1016/j.ejphar.2010.11.008
9
Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean-Frederic Blanc, Lunan Yan, Jijin Yang, Ligong Lu, Won-Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi-Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian B. Walters, Christine Dela Cruz, Valerie Poulart, Jian-Hua Wang. Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialHepatology 2014; 60(5): 1697 doi: 10.1002/hep.27290
10
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2005; : 91 doi: 10.1007/3-540-27194-5_8
11
Katerina Malagari, Mary Pomoni, Themistoklis N. Spyridopoulos, Hippokratis Moschouris, Alexis Kelekis, Spyros Dourakis, Efthymia Alexopoulou, John Koskinas, Michalis Angelopoulos, John Kornezos, Anastasia Pomoni, Savvas Tandeles, Athanasios Marinis, Spyros Rizos, Dimitrios Kelekis. Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead™: Results of 237 Hepatocellular Carcinoma (HCC) PatientsCardioVascular and Interventional Radiology 2011; 34(4): 774 doi: 10.1007/s00270-010-0044-3
12
Jannis Kountouras, Christos Zavos, Dimitrios Chatzopoulos. Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignanciesJournal of Surgical Oncology 2005; 90(4): 249 doi: 10.1002/jso.20254
13
Eng Soon Teoh. Medicinal Orchids of Asia2016; : 131 doi: 10.1007/978-3-319-24274-3_8
14
David J. Pennisi, Takashi Mikawa. Normal patterning of the coronary capillary plexus is dependent on the correct transmural gradient of FGF expression in the myocardiumDevelopmental Biology 2005; 279(2): 378 doi: 10.1016/j.ydbio.2004.12.028
15
David Semela, Jean-François Dufour. Signaling Pathways in Liver Diseases2010; : 421 doi: 10.1007/978-3-642-00150-5_28
16
Liang Liu, Zheng-Gang Ren, Yuan Shen, Xiao-Dong Zhu, Wei Zhang, Wei Xiong, Yi Qin, Zhao-You Tang. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transitionCancer Science 2010; 101(1): 120 doi: 10.1111/j.1349-7006.2009.01363.x
17
Yang Guo, Yue Zhang, Ning Jin, Rachel Klein, Jodi Nicolai, Robert J. Lewandowski, Robert K. Ryu, Reed A. Omary, Andrew C. Larson. Electroporation-Mediated Transcatheter Arterial Chemoembolization in the Rabbit VX2 Liver Tumor ModelInvestigative Radiology 2012; 47(2): 116 doi: 10.1097/RLI.0b013e31822e57cc
18
H. Cha, H. I. Yoon, I. J. Lee, W. S. Koom, K.-H. Han, J. Seong. Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinomaJournal of Radiation Research 2013; 54(6): 1069 doi: 10.1093/jrr/rrt034
19
Jean‐François Dufour, Hanno Hoppe, Markus H. Heim, Beat Helbling, Olivier Maurhofer, Zsolt Szucs‐Farkas, Ralph Kickuth, Markus Borner, Daniel Candinas, Bettina Saar. Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I StudyThe Oncologist 2010; 15(11): 1198 doi: 10.1634/theoncologist.2010-0180
20
Steven Lahti, Johannes M. Ludwig, Minzhi Xing, Lingyi Sun, Dexing Zeng, Hyun S. Kim, Yi-Hsien Hsieh. In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma—A pilot studyPLOS ONE 2017; 12(4): e0174539 doi: 10.1371/journal.pone.0174539
21
Li Li, Jia-Ling Huang, Qi-Cai Liu, Pei-Hong Wu, Ran-Yi Liu, Yi-Xin Zeng, Wen-Lin Huang. Endostatin gene therapy for liver cancer by a recombinant adenovirus deliveryWorld Journal of Gastroenterology 2004; 10(13): 1867-1871 doi: 10.3748/wjg.v10.i13.1867
22
Adriana Sergio, Chiara Cristofori, Romilda Cardin, Giorgio Pivetta, Roberto Ragazzi, Anna Baldan, Lisa Girardi, Umberto Cillo, Patrizia Burra, Anna Giacomin, Fabio Farinati. Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and InvasivenessThe American Journal of Gastroenterology 2008; 103(4): 914 doi: 10.1111/j.1572-0241.2007.01712.x
23
Sanjay Gupta, Satoshi Kobayashi, Sith Phongkitkarun, Lyle D. Broemeling, Zuxing Kan. Effect of Transcatheter Hepatic Arterial Embolization on Angiogenesis in an Animal ModelInvestigative Radiology 2006; 41(6): 516 doi: 10.1097/01.rli.0000209663.00629.8a
24
Jean-François Dufour. Targeted Therapies for Hepatocellular Carcinoma2011; : 74 doi: 10.2217/ebo.11.287
25
A. Lam, D. Fernando, C.C. Sirlin, M. Nayyar, S.C. Goodwin, D.K. Imagawa, C. Lall. Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisationClinical Radiology 2017; 72(11): 994.e9 doi: 10.1016/j.crad.2017.07.003
26
Mary A. Maluccio, Anne M. Covey, Leah Ben Porat, Joanna Schubert, Lynn A. Brody, Constantinos T. Sofocleous, George I. Getrajdman, William Jarnagin, Ronald DeMatteo, Leslie H. Blumgart, Yuman Fong, Karen T. Brown. Transcatheter Arterial Embolization with Only Particles for the Treatment of Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology 2008; 19(6): 862 doi: 10.1016/j.jvir.2008.02.013
27
Jean-Marc Idée, Boris Guiu. Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: A reviewCritical Reviews in Oncology/Hematology 2013; 88(3): 530 doi: 10.1016/j.critrevonc.2013.07.003
28
Zhen Fan Yang, Ronnie T.P. Poon, Yuqing Liu, Chi Keung Lau, David W. Ho, Ka Ho Tam, Chi Tat Lam, Sheung Tat Fan. High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesisMolecular Cancer Therapeutics 2006; 5(9): 2261 doi: 10.1158/1535-7163.MCT-06-0149
29
Min Xu, MB Majella Doyle, Babak Banan, Neeta Vachharajani, Xuanchuan Wang, Nael Saad, Kathryn Fowler, Elizabeth M. Brunt, Yiing Lin, William C. Chapman. Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver TransplantationJournal of the American College of Surgeons 2017; 225(1): 28 doi: 10.1016/j.jamcollsurg.2017.03.015